The United States could soon have another tool in the fight against respiratory syncytial virus, an illness that’s the No. 1 ...

Testing on June 7 by utility Aqua found elevated nitrate levels in water from the Kankakee River. Nitrates can be harmful to ...

Many health experts have applauded the effort, but some also worry that it could raise unnecessary fears that infant formulas ...

The Food and Drug Administration has approved a new drug from Merck designed to protect infants from respiratory syncytial ...

The U.S. Food and Drug Administration on Monday approved Merck's preventive antibody shot to protect infants up to one year ...

The FDA has approved Enflonsia (clesrovimab-cfor) for the prevention of RSV lower respiratory tract disease in neonates and ...

Antibiotic use in preterm infants is linked to gut microbiome changes, increasing susceptibility to infections and impacting ...

Aqua Illinois advises University Park, Peotone and Kankakee residents not to give tap water to infants due to high nitrate ...

Screening can now determine their risk for an ever-growing list of conditions — including ones we can’t do much about.

The FDA approved the monoclonal antibody clesrovimab-cfor for the prevention of respiratory syncytial virus lower respiratory ...

The simplicity of Merck's monoclonal antibody for RSV in infants could be a plus in its competition with AstraZeneca's existing treatment.

As newborn screening and rapid DNA sequencing become routine, we are poised to catch and treat inherited diseases at their ...